Eli Lilly and Co Q4 2022 Earnings Call Summary - Thomson StreetEvents

Eli Lilly and Co Q4 2022 Earnings Call Summary

Eli Lilly and Co Q4 2022 Earnings Call Summary - Thomson StreetEvents
Eli Lilly and Co Q4 2022 Earnings Call Summary
Published Feb 02, 2023
23 pages (13459 words) — Published Feb 02, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of LLY.N earnings conference call or presentation 2-Feb-23 3:00pm GMT

  
Brief Excerpt:

...A. Highlights: 2022 was a year of strong pipeline and commercial performance for LLY. 1. Delivered top and bottom line growth in 2022 despite the impact of Alimta LOE in US and significant FX headwinds, and delivered another remarkable year of pipeline progress. a. 2. Co. began 2023 with multiple updates to late-stage pipeline. 3. In 2Q22 earnings call last Aug., Co. announced the filing of submissions for two assets with FDA under an accelerated approval pathway: pirtobrutinib in mantle cell lymphoma and donanemab in early symptomatic Alzheimer's disease. a. Last month, Co. received response from FDA on both these assets. b. On Jan. 19, Co. announced that FDA issued a complete response letter for accelerated approval of donanemab due to limited number of patients with at least 12 months of drug exposure. There were no other deficiencies cited. i. c. Co. will continue to work with FDA to evaluate the best pathway to make this potential treatment option available to patients and look forward...

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
Eli Lilly and Co
Ticker
LLY.N
Time
3:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Eli Lilly and Co Q1 2023 Earnings Call Summary – 2023-04-27 – US$ 54.00 – Edited Brief of LLY.N earnings conference call or presentation 27-Apr-23 2:00pm GMT

Eli Lilly and Co at Cowen Health Care Conference Transcript – 2023-03-06 – US$ 54.00 – Edited Transcript of LLY.N presentation 6-Mar-23 6:30pm GMT

Eli Lilly and Co at SVB Securities Global Biopharma Conference (Virtual) Transcript – 2023-02-16 – US$ 54.00 – Edited Transcript of LLY.N presentation 16-Feb-23 5:00pm GMT

Eli Lilly and Co at Guggenheim Healthcare Talks Oncology Day Transcript – 2023-02-09 – US$ 54.00 – Edited Transcript of LLY.N presentation 9-Feb-23 3:10pm GMT

Eli Lilly and Co Q4 2022 Earnings Call Transcript – 2023-02-02 – US$ 54.00 – Edited Transcript of LLY.N earnings conference call or presentation 2-Feb-23 3:00pm GMT

Eli Lilly and Co at JPMorgan Healthcare Conference Transcript – 2023-01-10 – US$ 54.00 – Edited Transcript of LLY.N presentation 10-Jan-23 11:45pm GMT

Eli Lilly and Co Guidance Call 2023 Summary – 2022-12-13 – US$ 54.00 – Edited Brief of LLY.N guidance conference call or presentation 13-Dec-22 2:00pm GMT

Eli Lilly and Co at Evercore ISI HealthCONx Conference (Virtual) Transcript – 2022-11-30 – US$ 54.00 – Edited Transcript of LLY.N presentation 30-Nov-22 5:10pm GMT

Eli Lilly and Co Q3 2022 Earnings Call Summary – 2022-11-01 – US$ 54.00 – Edited Brief of LLY.N earnings conference call or presentation 1-Nov-22 1:00pm GMT

Eli Lilly and Co Q3 2022 Earnings Call Transcript – 2022-11-01 – US$ 54.00 – Edited Transcript of LLY.N earnings conference call or presentation 1-Nov-22 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Eli Lilly and Co Q4 2022 Earnings Call Summary" Feb 02, 2023. Alacra Store. May 13, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2022-Eli-Lilly-and-Co-Earnings-Call-B15413518>
  
APA:
Thomson StreetEvents. (2023). Eli Lilly and Co Q4 2022 Earnings Call Summary Feb 02, 2023. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2022-Eli-Lilly-and-Co-Earnings-Call-B15413518>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.